All Transactions - Bryan, Garnier & Co

Our transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Lhyfe on its landmark €110m IPO on Euronext Paris

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering of shares and warrants

Bryan, Garnier & Co acts as Lead Joint Bookrunner to leading German Specialty Pharmaceuticals provider Medios AG on its EUR 93 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to leading global IoT satellite operator Astrocast on its private placement and subsequent direct listing on Euronext Growth, securing a total of CHF 45 million for the company

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Enapter Follow-On Offering of EUR 30m

Bryan, Garnier & Co acts as Joint Bookrunner on Valneva’s Nasdaq & Euronext Paris USD 102m Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on its acquisition of STAR Teams, and as Joint Global Coordinator on subsequent SEK 250 million Follow-on Offering

Bryan, Garnier & Co is proud to act as Sole Financial Advisor, Sole Global Coordinator & Joint Bookrunner to Waga Energy on its EUR 126m Initial Public Offering including Strategic Investments from Vitol, CMA CGM and Viva Energy

Bryan, Garnier & Co acts as Sole Advisor and Sole Global Coordinator on Claranova’s EUR 65 million PIPE

Bryan, Garnier & Co acts as Joint Bookrunner on BICO’s SEK 2 billion Follow-on Offering

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on BALYO’s EUR 7.8 million Follow-on Offering

Bryan, Garnier & Co acts as Joint Bookrunner on Mister Spex’s EUR 326 million Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Strategic Advisor, Sole Global Coordinator and Joint Bookrunner to HDF Energy on its EUR 132.2 million Initial Public Offering including Strategic Investments from Rubis and Teréga

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on Heidelberg Pharma’s EUR 20 million Follow-on Offering

Bryan, Garnier & Co acts as Joint Bookrunner on Swedish Stirling’s SEK 225 million Follow-on Offering

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 100.4 million Marketed Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner to LMK Group on its SEK 550 million Initial Public Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to GenSight on its EUR 30 million Follow-on Offering

GenSight_2021_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 596 million Follow-on Offering

Azelio_website_tombstone_march2021

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Basilea Pharmaceutica on its CHF 46 million Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to MedinCell on its EUR 30 million Follow-on Offering

Medincell_website_tombstone

Bryan, Garnier & Co helps Zealand Pharma raise DKK 749 million from the global capital markets via an accelerated bookbuild

Zealand_Pharma_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering

Nicox_website_tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Proparco on its EUR 23 million Secondary Offering of Voltalia shares

Voltalia_website_tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Abivax on its EUR 28 million Follow-on Offering

Abivax_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering

Tombstone_gensight

Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies

McPhy_website_tombstone_4

Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors

website_tombstone_2

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering

tombstone_humanigen_78200000_dollars

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 270 million Follow-on Offering

Azelio tombstone 2

Bryan, Garnier & Co acts as Co-manager to BioNTech on its USD511.5 million upsized Publicly-marketed Follow-on Offering

BioNTech_website_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 37 million upsized Follow-on Offering

Carbios website tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator on a EUR 7.3 million Rights Issue for medtech company Pixium Vision

Pixium_website_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on MedinCell’s Follow-on with top-tier European biotech specialists and institutional investors

Medincell_website_tombstone

Bryan Garnier & Co acts as Joint Bookrunner and Joint Broker to AIM-listed 4D Pharma on its GBP 22 million equity Fund Raising

4Dpharma_website_tombstone

Bryan, Garnier & Co acts as Sole Bookrunner on GeNeuro EUR17.5 million Private Placement

GeNeuro_website_tombstone

Bryan, Garnier & Co accompanies DBV on its USD 143 million NASDAQ Follow-on

DBV_website_tombstone_2019

Bryan, Garnier & Co acts as Joint Bookrunner to BioNTech on its USD 150 million Nasdaq Initial Public Offering

Biontech_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunning Manager on Celyad’s USD 20 million global equity offering

Celyad_website_tombstone

Bryan, Garnier & Co acts as Sole Bookrunner on Carbios EUR 14.5million Private Placement

Carbios_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to Genfit on its $155.4 million Nasdaq Initial Public Offering

Genfit tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for MedinCell’s €30 million Euronext Paris IPO

MedinCell tombstone

Bryan, Garnier & Co acts as Joint Bookrunner on Materialise’s USD45 million Follow–On Equity Offering on Nasdaq

Materialise tombstone

Bryan, Garnier & Co acts as Sole Bookrunner on ASIT biotech EUR12 million Convertible Bond Placement

ASIT biotech tombstone

Bryan, Garnier & Co acts as Co-manager on Canopy Growth’s benchmark CAD600 million Convertible Bond New Issue

Canopy_2018_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Voluntis’ IPO, the first ever listing of a digital therapeutics company raising EUR30.1 million

Voluntis tombstone

Bryan, Garnier & Co acts as Lead Manager on Medigene’s EUR48.3 million offering

Medigene tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator on Celyad’s EUR46.1 million global equity offering

Celyad tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Medartis’ IPO CHF142.6 million on SIX Swiss Exchange

Medartis tombstone

Bryan, Garnier & Co part of bulge bracket syndicate for DBV $150 million Follow-on

DBV tombstone

Bryan, Garnier & Co advises Bone Therapeutics on its €19.45 million convertible bond placement

Bone Therapeutics tombstone